Cargando…

Liraglutide therapy beyond glycemic control: an observational study in Indian patients with type 2 diabetes in real world setting

BACKGROUND: Liraglutide is an analog of human glucagon-like peptide-1 (GLP-1) and acts as a GLP-1 receptor agonist. Liraglutide is presently used in the treatment of selected patients with type 2 diabetes mellitus (T2DM). OBJECTIVE: To assess efficacy and safety of liraglutide in, overweight and obe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kesavadev, Jothydev, Shankar, Arun, Krishnan, Gopika, Jothydev, Sunitha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333831/ https://www.ncbi.nlm.nih.gov/pubmed/22536087 http://dx.doi.org/10.2147/IJGM.S27886

Ejemplares similares

Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy
por: Kesavadev, Jothydev, et al.
Publicado: (2015)

Real-World User and Clinician Perspective and Experience with MiniMed™ 780G Advanced Hybrid Closed Loop System
por: Kesavadev, Jothydev, et al.
Publicado: (2023)

Sitagliptin 100 mg vs glimepiride 1–3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM)
por: Kesavadev, Jothydev, et al.
Publicado: (2017)

Digital health and diabetes: experience from India
por: Kesavadev, Jothydev, et al.
Publicado: (2021)

Time-in-range as a target in type 2 diabetes: An urgent need
por: Saboo, Banshi, et al.
Publicado: (2021)

Evolution of Insulin Delivery Devices: From Syringes, Pens, and Pumps to DIY Artificial Pancreas
por: Kesavadev, Jothydev, et al.
Publicado: (2020)

Management Strategies for Dealing With Surges of the COVID-19 Pandemic
por: Raveendran, A.V., et al.
Publicado: (2021)

The Do-It-Yourself Artificial Pancreas: A Comprehensive Review
por: Kesavadev, Jothydev, et al.
Publicado: (2020)

Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Trivandrum cohort of the A(1)chieve study
por: Kesavadev, Jothydev
Publicado: (2013)

Human Digital Twin for Personalized Elderly Type 2 Diabetes Management
por: Thamotharan, Padmapritha, et al.
Publicado: (2023)

Reducing the Cost of Diabetes Care with Telemedicine, Smartphone, and Home Monitoring
por: Kesavadev, Jothydev, et al.
Publicado: (2023)

IDF21-0236 Prevalence of Breakthrough Covid Infections and Its Severity among Vaccinated Individuals
por: Kesavadev, J., et al.
Publicado: (2022)

A new interventional home care model for COVID management: Virtual Covid IP
por: Kesavadev, Jothydev, et al.
Publicado: (2021)

Suggested use of vaccines in diabetes
por: Kesavadev, Jothydev, et al.
Publicado: (2012)

Low dose liraglutide in Indian patients with type 2 diabetes in the real world setting
por: Sanyal, Debmalya, et al.
Publicado: (2013)

Expert Opinion: Optimum Clinical Approach to Combination-Use of SGLT2i + DPP4i in the Indian Diabetes Setting
por: Chadha, Manoj, et al.
Publicado: (2022)

Sodium-glucose Cotransporter-2 Inhibitors in Combination with Other Glucose-lowering Agents for the Treatment of Type 2 Diabetes Mellitus
por: Kalra, Sanjay, et al.
Publicado: (2018)

Unproven Therapies for Diabetes and Their Implications
por: Kesavadev, Jothydev, et al.
Publicado: (2016)

Long-term efficacy of liraglutide in Indian patients with Type 2 diabetes in a real-world setting
por: Kaur, Parjeet, et al.
Publicado: (2016)

Expert Consensus Recommendations on Time in Range for Monitoring Glucose Levels in People with Diabetes: An Indian Perspective
por: Mohan, Viswanathan, et al.
Publicado: (2023)

IDF21-0234 The Virtual COVID In-patient (VCIP) Care and Post Covid Symptoms: a Comparison with Conventional Care
por: Kesavadev, J., et al.
Publicado: (2022)

Barriers and solutions to diabetes management: An Indian perspective
por: Wangnoo, Subhash K., et al.
Publicado: (2013)

Real-World Evaluation of Glycemic Outcomes and Extra-Glycemic Parameters in Diabetic Patients Treated with the Combined Formulation Degludec–Liraglutide (Ideglira)
por: Zenari, Luciano, et al.
Publicado: (2020)

One-year safety and effectiveness of insulin degludec in patients with diabetes mellitus in routine clinical practice in India—TRUST (Tresiba real-world use study)
por: Kesavadev, Jothydev, et al.
Publicado: (2022)

Evolving Scope of Clinical Empathy in the Current Era of Medical Practice
por: B, Jayakrishnan, et al.
Publicado: (2023)

Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting
por: Simioni, N., et al.
Publicado: (2018)

Understanding Patients’ Willingness to Pay for Biphasic Insulin Aspart 30/70 in a Pen Device for Type 2 Diabetes Treatment in an Out-of-Pocket Payment Market
por: Murthy, Sreenivasa, et al.
Publicado: (2021)

Steroid use during COVID-19 infection and hyperglycemia – What a physician should know
por: Sosale, Aravind, et al.
Publicado: (2021)

Real-World Cost-Effectiveness: Lower Cost of Treating Patients to Glycemic Goal with Liraglutide versus Exenatide
por: DeKoven, Mitch, et al.
Publicado: (2014)

Real‐world data reveal unmet clinical needs in insulin treatment in Asian people with type 2 diabetes: the Joint Asia Diabetes Evaluation (JADE) Register
por: Kong, Alice P. S., et al.
Publicado: (2020)

Blood glucose levels should be considered as a new vital sign indicative of prognosis during hospitalization
por: Kesavadev, Jothydev, et al.
Publicado: (2021)

Liraglutide and Dulaglutide therapy in addition to SGLT-2 inhibitor and metformin treatment in Indian type 2 diabetics: a real world retrospective observational study
por: Ghosal, S., et al.
Publicado: (2018)

Challenges in Type 1 diabetes management in South East Asia: Descriptive situational assessment
por: Kesavadev, Jothydev, et al.
Publicado: (2014)

The SAGE study: Global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM
por: Renard, Eric, et al.
Publicado: (2021)

Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review
por: Ostawal, Amrita, et al.
Publicado: (2016)

Is there an association between liraglutide use and female breast cancer in a real-world setting?
por: Funch, Donnie, et al.
Publicado: (2018)

Liraglutide – Indian Experience
por: Anirban, Majumder, et al.
Publicado: (2018)

Real-world glycemic outcomes in patients with type 2 diabetes initiating exenatide once weekly and liraglutide once daily: a retrospective cohort study
por: Saunders, William B, et al.
Publicado: (2016)

Insulinization in T2DM with Basal Analogues During COVID-19 Pandemic: Expert Opinion from an Indian Panel
por: Chawla, Manoj, et al.
Publicado: (2020)

Clinical Effects of Liraglutide in a Real-World Setting in Spain: eDiabetes-Monitor SEEN Diabetes Mellitus Working Group Study
por: Mezquita-Raya, Pedro, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_kmginfh17ghcgid9nl1tjbuerb